Welcome to Hologic Investor Relations

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Wednesday, August 2, 2017
4:30pm - 5:30pm EDT
Recent News
Sep 14, 2017

Hologic, Inc. (Nasdaq: HOLX) is deeply concerned that the United States Preventive Services Task Force (USPSTF) did not include a grade for co-testing (also known as Pap+HPV Together) in draft...

Sep 11, 2017

Hologic’s 3Dimensions™ Mammography System Now Available in Europe Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort

Aug 31, 2017

Hologic, Inc. (Nasdaq: HOLX) today announced U.S. commercial availability of the Brevera® breast biopsy system with CorLumina® imaging technology, a groundbreaking real-time breast biopsy and...

Aug 2, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal third quarter ended July 1, 2017. GAAP diluted earnings per share (EPS) of $0.21 decreased (30.0%)...

More ›